sellModerate
Peter Kamin sold $754k of PMD
director, owner at PSYCHEMEDICS CORP. 320,708 shares at an average of $2.35, traded Dec 10, 2024, filed Dec 12, 2024.
Warning score
42Value
$754k
320,708 shares
Holdings after
1,499,710
-18% from before
From 52-week low
-
no price yet
From 52-week high
-
no price yet
Score components
- +15RoleDirector
- +22Trade size$754k at market
- +5Share of holdings soldSold 18% of holdings
- 0ClusterNo other insider selling within 14 days
What happened after comparable sells
Same side and tier, against the S&P 500, at 1, 3 and 6 months. Shown to Pro users; the whole table is on the backtest page.
Rows in this filing
Every transaction in Form 4 0001420506-24-002619, as filed. Open on EDGAR
| Date | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|
| Dec 10, 2024 | SOpen-market sale Common Stock, $0.005 Par Valueindirect: See footnote | -320,708 | $2.35 | $754k | 1,499,710 | Dec 12, 2024 |
Related signals
Other insiders at PSYCHEMEDICS CORP and this insider’s other filings.
| Score | Company | Insider | Value | Holdings | Filed |
|---|---|---|---|---|---|
| 40Moderate | PSYCHEMEDICS CORP | Powell Anderson Capital Partners LLC owner | $305k 159,700 shares | +32% | |
| 34Weak | PSYCHEMEDICS CORP | Powell Anderson Capital Partners LLC owner | $232k 86,991 shares | +21% | |
| 58Moderate | PSYCHEMEDICS CORP | Peter Kamin director, owner | $3.3M 1,409,712 shares | +343% |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.